Plasma cell differentiation requires the transcription factor XBP-1

Considerable progress has been made in identifying the transcription factors involved in the early specification of the B-lymphocyte lineage. However, little is known about factors that control the transition of mature activated B cells to antibody-secreting plasma cells. Here we report that the transcription factor XBP-1 is required for the generation of plasma cells. XBP-1 transcripts were rapidly upregulated in vitro by stimuli that induce plasma-cell differentiation, and were found at high levels in plasma cells from rheumatoid synovium. When introduced into B-lineage cells, XBP-1 initiated plasma-cell differentiation. Mouse lymphoid chimaeras deficient in XBP-1 possessed normal numbers of activated B lymphocytes that proliferated, secreted cytokines and formed normal germinal centres. However, they secreted very little immunoglobulin of any isotype and failed to control infection with the B-cell-dependent polyoma virus, because plasma cells were markedly absent. XBP-1 is the only transcription factor known to be selectively and specifically required for the terminal differentiation of B lymphocytes to plasma cells.

[1]  F. Alt,et al.  Antigen-Independent Appearance of Recombination Activating Gene (Rag)-Positive Bone Marrow B Cells in the Spleens of Immunized Mice , 2000, The Journal of experimental medicine.

[2]  R. Sanderson,et al.  B lymphocytes express and lose syndecan at specific stages of differentiation. , 1989, Cell regulation.

[3]  Mark M. Davis,et al.  Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells , 1994, Cell.

[4]  J. Choe,et al.  IL‐10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells , 1998, European journal of immunology.

[5]  Laurie H Glimcher,et al.  A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.

[6]  K. Calame,et al.  Repression of c-myc Is Necessary but Not Sufficient for Terminal Differentiation of B Lymphocytes In Vitro , 2000, Molecular and Cellular Biology.

[7]  M. McHeyzer-Williams,et al.  B cell memory and the long-lived plasma cell. , 1999, Current opinion in immunology.

[8]  K. Takatsu Cytokines Involved in B-Cell Differentiation and Their Sites of Action , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[9]  J Bajorath,et al.  Immune regulation by CD40 and its ligand GP39. , 1996, Annual review of immunology.

[10]  M. Glimcher,et al.  In situ hybridization studies suggest a role for the basic region‐leucine zipper protein hXBP‐1 in exocrine gland and skeletal development during mouse embryogenesis , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.

[11]  D. Schliephake,et al.  Blimp‐1 overcomes the block in IgM secretion in lipopolysaccharide / anti‐μ F(ab′)2‐co‐stimulated B lymphocytes , 1996, European journal of immunology.

[12]  G. Cattoretti,et al.  Commitment of B Lymphocytes to a Plasma Cell Fate Is Associated with Blimp-1 Expression In Vivo1 , 2000, The Journal of Immunology.

[13]  N. Zeleznik-Le,et al.  A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. , 1990, Science.

[14]  K. Calame,et al.  Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. , 1997, Science.

[15]  F. Alt,et al.  RAG-2-Deficient Blastocyst Complementation , 1994 .

[16]  F. Melchers B-lymphocyte-lineage cells from early precursors to Ig-secreting plasma cells: targets of regulation by the myc/mad/max families of genes? , 1997, Current topics in microbiology and immunology.

[17]  L. Glimcher,et al.  Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. , 1996, Immunity.

[18]  V. Stewart,et al.  RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Mak,et al.  Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function , 1997, Science.

[20]  R. Wall,et al.  Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation , 1993, Molecular and cellular biology.

[21]  M. Bachmann,et al.  The role of B cells in acute and chronic infections. , 1999, Current opinion in immunology.

[22]  Yau-Tsun Steven Li,et al.  Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1 , 1996, The Journal of experimental medicine.

[23]  R. Ashman,et al.  Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. , 1993, Journal of immunology.

[24]  J. Kearney,et al.  Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. , 1997, Journal of immunology.

[25]  K. Calame,et al.  Transcriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase , 2000, Molecular and Cellular Biology.

[26]  A. Ladd,et al.  In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. , 1991, Arthritis and rheumatism.

[27]  F. Alt,et al.  Class Switching in B Cells Lacking 3′ Immunoglobulin Heavy Chain Enhancers , 1998, The Journal of experimental medicine.

[28]  M. Shlomchik,et al.  Antigen drives very low affinity B cells to become plasmacytes and enter germinal centers. , 1998, Journal of immunology.

[29]  D. Franklin,et al.  Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. , 1997, Immunity.

[30]  John Calvin Reed,et al.  Reversal of EBV immortalization precedes apoptosis in IL-6-induced human B cell terminal differentiation. , 1997, Immunity.

[31]  I. Verma,et al.  Immunological defects in mice with a targeted disruption in Bcl-3. , 1997, Genes & development.

[32]  J. Uhr,et al.  Lymphokine-induced IgM secretion by clones of neoplastic B cells , 1983, Nature.

[33]  I. Berberich,et al.  Reversal of Blimp‐1‐mediated apoptosis by A1, a member of the Bcl‐2 family , 1999, European journal of immunology.

[34]  A. Leonardi,et al.  Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture , 1998, The Journal of experimental medicine.

[35]  S. Orkin,et al.  An essential role in liver development for transcription factor XBP-1. , 2000, Genes & development.

[36]  Mark M. Davis,et al.  Differential Effect of B Lymphocyte–induced Maturation Protein (Blimp-1) Expression on Cell Fate during B Cell Development , 1998, The Journal of experimental medicine.

[37]  P G Soro,et al.  Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells. , 1999, Journal of immunology.

[38]  R. Garcea,et al.  The Role of CD40-CD154 Interaction in Antiviral T Cell-Independent IgG Responses1 , 2000, The Journal of Immunology.

[39]  C. Berek,et al.  Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. , 1999, Journal of immunology.

[40]  R. Welsh,et al.  T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice , 1996, The Journal of experimental medicine.

[41]  David Gray,et al.  Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.

[42]  L. Glimcher,et al.  Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells. , 1999, International journal of oncology.

[43]  A. M. Morrison,et al.  Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation. , 1998, Seminars in immunology.

[44]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[45]  M. Blackman,et al.  A model system for peptide hormone action in differentiation: Interleukin 2 induces a B lymphoma to transcribe the J chain gene , 1986, Cell.

[46]  J. Banchereau,et al.  Regulation of B-cell commitment to plasma cells or to memory B cells. , 1997, Seminars in immunology.

[47]  L. Glimcher,et al.  Transcription Factors in Lymphocyte Development— T and B Cells Get Together , 1999, Cell.

[48]  K. Calame,et al.  Transcriptional regulation during B cell development. , 1998, Annual review of immunology.

[49]  L. Staudt,et al.  Control of inflammation, cytokine expression, and germinal center formation by BCL-6. , 1997, Science.

[50]  J. Banchereau,et al.  Generation of memory B cells and plasma cells in vitro , 1995, Science.